FUVA BRAIN LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 708 JPY | -1.26% |
|
+5.83% | +23.78% |
Valuation
| Fiscal Period: March | 2022 | 2023 |
|---|---|---|
| Capitalization 1 | 3,903 | 3,230 |
| Enterprise Value (EV) 1 | 2,560 | 1,899 |
| P/E ratio | -134 x | 124 x |
| Yield | - | - |
| Capitalization / Revenue | 2.32 x | 1.38 x |
| EV / Revenue | 1.52 x | 0.81 x |
| EV / EBITDA | -69.2 x | 22.3 x |
| EV / FCF | - | 25,705,543 x |
| FCF Yield | - | 0% |
| Price to Book | 2.84 x | 2.3 x |
| Nbr of stocks (in thousands) | 5,339 | 5,339 |
| Reference price 2 | 731.0 | 605.0 |
| Announcement Date | 6/27/22 | 6/26/23 |
1JPY in Million2JPY
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: March | 2022 | 2023 |
|---|---|---|
| Net sales 1 | 1,682 | 2,338 |
| EBITDA 1 | -37 | 85 |
| EBIT 1 | -58 | 59 |
| Operating Margin | -3.45% | 2.52% |
| Earnings before Tax (EBT) 1 | -46 | 51 |
| Net income 1 | -29 | 26 |
| Net margin | -1.72% | 1.11% |
| EPS 2 | -5.436 | 4.870 |
| Free Cash Flow | - | 73.88 |
| FCF margin | - | 3.16% |
| FCF Conversion (EBITDA) | - | 86.91% |
| FCF Conversion (Net income) | - | 284.13% |
| Dividend per Share | - | - |
| Announcement Date | 6/27/22 | 6/26/23 |
1JPY in Million2JPY
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: March | 2020 S1 | 2021 S1 |
|---|---|---|
| Net sales 1 | 475 | 547 |
| EBITDA | - | - |
| EBIT 1 | -52 | -46 |
| Operating Margin | -10.95% | -8.41% |
| Earnings before Tax (EBT) 1 | -52 | -42 |
| Net income 1 | -55 | -45 |
| Net margin | -11.58% | -8.23% |
| EPS 2 | -13.28 | -9.200 |
| Dividend per Share 2 | - | - |
| Announcement Date | 11/13/19 | 11/12/20 |
1JPY in Million2JPY
Estimates
Balance Sheet Analysis
| Fiscal Period: March | 2022 | 2023 |
|---|---|---|
| Net Debt 1 | - | - |
| Net Cash position 1 | 1,343 | 1,331 |
| Leverage (Debt/EBITDA) | - | - |
| Free Cash Flow | - | 73.9 |
| ROE (net income / shareholders' equity) | - | 2.13% |
| ROA (Net income/ Total Assets) | - | 1.35% |
| Assets 1 | - | 1,924 |
| Book Value Per Share 2 | 258.0 | 263.0 |
| Cash Flow per Share 2 | 252.0 | 265.0 |
| Capex 1 | 6 | 9 |
| Capex / Sales | 0.36% | 0.38% |
| Announcement Date | 6/27/22 | 6/26/23 |
1JPY in Million2JPY
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| +23.78% | 23.81M | |
| +7.99% | 320B | |
| +21.67% | 213B | |
| -1.02% | 148B | |
| +8.43% | 56.08B | |
| +6.57% | 32.39B | |
| -2.61% | 28.25B | |
| +69.74% | 22.8B | |
| +23.11% | 20.04B | |
| +12.20% | 14.82B |
- Stock Market
- Equities
- 3927 Stock
- Financials Fuva Brain Limited
